Carmen Roncal Selected Research

Carmen Roncal Research Topics

Disease

7	Atherosclerosis 05/2024 - 04/2010
7	Peripheral Arterial Disease 01/2022 - 02/2015
6	Myocardial Infarction 03/2021 - 11/2007
5	Ischemic Stroke 04/2024 - 08/2017
5	Thrombosis (Thrombus) 04/2024 - 06/2012
4	Stroke (Strokes) 12/2023 - 08/2017
4	Ischemia 10/2018 - 03/2010
4	Hypoxia (Hypoxemia) 03/2015 - 03/2010
3	Inflammation (Inflammations) 05/2024 - 06/2012
3	Hemorrhage 08/2022 - 01/2019
3	Neoplasms (Cancer) 01/2014 - 02/2011
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 08/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2021
2	Vascular Calcification 01/2020 - 11/2018
1	Atrial Fibrillation 04/2024
1	Fibrosis (Cirrhosis) 01/2023
1	Heart Failure 01/2023
1	Infections 10/2022
1	Aneurysm (Aneurysms) 05/2022
1	Abdominal Aortic Aneurysm 05/2022
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2022
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2022
1	Muscular Dystrophies (Muscular Dystrophy) 12/2021
1	Albuminuria 05/2021
1	Hematoma 01/2020
1	Diabetes Mellitus 01/2019
1	ST Elevation Myocardial Infarction 10/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2017
1	Coronary Disease (Coronary Heart Disease) 11/2017
1	Brain Ischemia (Cerebral Ischemia) 08/2017
1	Vascular Remodeling 02/2015
1	Intermittent Claudication 02/2015
1	Chronic Limb-Threatening Ischemia 02/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2014
1	Necrosis 06/2013
1	Reperfusion Injury 03/2010
1	Disseminated Intravascular Coagulation 12/2009
1	Hypertrophy 11/2007

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 05/2024 - 11/2017
4	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2015
4	Matrix Metalloproteinases (MMPs)IBA 12/2021 - 02/2015
3	Hemostatics (Antihemorrhagics)IBA 12/2023 - 01/2021
3	Plasminogen Activator Inhibitor 1IBA 08/2022 - 02/2006
3	Apolipoproteins E (ApoE)IBA 05/2021 - 04/2010
3	Matrix Metalloproteinase 10 (Stromelysin 2)IBA 01/2021 - 02/2015
3	Thrombin FDA Link 08/2017 - 12/2009
3	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 06/2013 - 03/2010
2	FibrinIBA 12/2023 - 01/2021
2	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2023 - 02/2015
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022 - 01/2020
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 08/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2014 - 11/2007
2	Oxygen (Dioxygen)IBA 12/2010 - 03/2010
1	CholesterolIBA 05/2024
1	Factor XIII (Coagulation Factor XIII)IBA 12/2023
1	Procollagen Type IIBA 01/2023
1	Collagen Type I (Type I Collagen)IBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	procollagen type I carboxy terminal peptide (PICP)IBA 01/2023
1	Plasminogen Activators (Plasminogen Activator)IBA 08/2022
1	Warfarin (Coumadin)FDA LinkGeneric 08/2022
1	4- (4- ((3- (hydroxycarbamoyl)- 8- azaspiro(4.5)decan- 3- yl)sulfonyl)phenoxy)- N- methylbenzamideIBA 08/2022
1	AnticoagulantsIBA 08/2022
1	RivaroxabanIBA 08/2022
1	Interleukin-6 (Interleukin 6)IBA 08/2022
1	fibrin fragment D (D-dimer)IBA 05/2022
1	Lipocalin-2IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 05/2021
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 01/2021
1	von Willebrand FactorIBA 01/2021
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2020
1	trimethyloxamine (trimethylamine N-oxide)IBA 10/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2019
1	calcium phosphateIBA 11/2018
1	Connexin 43 (Connexin43)IBA 10/2018
1	HDL CholesterolIBA 11/2017
1	Neuroprotective AgentsIBA 08/2017
1	ChemokinesIBA 03/2015
1	matrigelIBA 07/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014
1	Thromboplastin (Tissue Factor)IBA 01/2014
1	Transcription Factors (Transcription Factor)IBA 08/2012
1	CD40 Ligand (CD40L)IBA 06/2012
1	Blocking AntibodiesIBA 02/2011
1	Monoclonal AntibodiesIBA 02/2011
1	Cell Adhesion MoleculesIBA 02/2011
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 02/2011
1	E-SelectinIBA 02/2011
1	EnzymesIBA 03/2010
1	Small Interfering RNA (siRNA)IBA 03/2010
1	Vascular Endothelial Growth Factor BIBA 11/2007
1	Phosphotransferases (Kinase)IBA 11/2007

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2021
2	Surgical Amputation (Amputations) 03/2021 - 11/2017
1	Secondary Prevention 04/2024
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2021
1	Thrombectomy 01/2021
1	Carotid Endarterectomy 11/2018
1	Drug Therapy (Chemotherapy) 08/2012
1	Aftercare (After-Treatment) 02/2011